Medavail Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $8.8
- Today's High:
- $8.8
- Open Price:
- $8.8
- 52W Low:
- $7.1
- 52W High:
- $58
- Prev. Close:
- $8.8
- Volume:
- 199
Company Statistics
- Market Cap.:
- $11.46 million
- Book Value:
- 14.279
- Revenue TTM:
- $43.33 million
- Operating Margin TTM:
- -104.11%
- Gross Profit TTM:
- $2.15 million
- Profit Margin:
- -106.17%
- Return on Assets TTM:
- -68.15%
- Return on Equity TTM:
- -194.67%
Company Profile
Medavail Holdings Inc had its IPO on 2010-05-03 under the ticker symbol MDVL.
The company operates in the Healthcare sector and Pharmaceutical Retailers industry. Medavail Holdings Inc has a staff strength of 279 employees.
Stock update
Shares of Medavail Holdings Inc opened at $8.8 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $8.8 - $8.8, and closed at $8.8.
This is a 0% increase from the previous day's closing price.
A total volume of 199 shares were traded at the close of the day’s session.
In the last one week, shares of Medavail Holdings Inc have increased by +4.14%.
Medavail Holdings Inc's Key Ratios
Medavail Holdings Inc has a market cap of $11.46 million, indicating a price to book ratio of 0.9478 and a price to sales ratio of 0.6766.
In the last 12-months Medavail Holdings Inc’s revenue was $43.33 million with a gross profit of $2.15 million and an EBITDA of $-40524000. The EBITDA ratio measures Medavail Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Medavail Holdings Inc’s operating margin was -104.11% while its return on assets stood at -68.15% with a return of equity of -194.67%.
In Q2, Medavail Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 25.4%.
Medavail Holdings Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-35.56 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medavail Holdings Inc’s profitability.
Medavail Holdings Inc stock is trading at a EV to sales ratio of 0.3764 and a EV to EBITDA ratio of -0.3322. Its price to sales ratio in the trailing 12-months stood at 0.6766.
Medavail Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $29.91 million
- Total Liabilities
- $4.16 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $92000
- Dividend Payout Ratio
- 0%
Medavail Holdings Inc ended 2024 with $29.91 million in total assets and $0 in total liabilities. Its intangible assets were valued at $29.91 million while shareholder equity stood at $23.05 million.
Medavail Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $4.16 million in other current liabilities, 2000.00 in common stock, $-262827000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $14.36 million and cash and short-term investments were $14.36 million. The company’s total short-term debt was $208,000 while long-term debt stood at $1.51 million.
Medavail Holdings Inc’s total current assets stands at $27.05 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $292000.00 compared to accounts payable of $796000.00 and inventory worth $10.07 million.
In 2024, Medavail Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $92000.
Comparatively, Medavail Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $8.8
- 52-Week High
- $58
- 52-Week Low
- $7.1
- Analyst Target Price
- $4
Medavail Holdings Inc stock is currently trading at $8.8 per share. It touched a 52-week high of $58 and a 52-week low of $58. Analysts tracking the stock have a 12-month average target price of $4.
Its 50-day moving average was $11.13 and 200-day moving average was $15.02 The short ratio stood at 0.55 indicating a short percent outstanding of 0%.
Around 1461.1% of the company’s stock are held by insiders while 8423.1% are held by institutions.
Frequently Asked Questions About Medavail Holdings Inc
Similar Industry Stocks (Pharmaceutical Retailers)
Most Active
Top Gainers
Top Losers
About
MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona.